Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析

◆英語タイトル:Fujimori Kogyo Co., Ltd. (7917) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA8011664
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月12日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:紙・包装
◆販売価格オプション(消費税別)
Single UserUSD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Fujimori Kogyo Co., Ltd. (7917) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fujimori Kogyo Co., Ltd. (Fujimori) is a general packaging materials company. It manufactures and markets plastic wrapping materials for the pharmaceuticals and food industries. Its products include medical and pharmaceutical products, electronics, optoelectronics, daily commodities, and food and distribution. In addition, it provides single-use bag for bio-pharmaceutical production processes and microbiological cultures, plant culture bags, packaging materials for pharmaceutical products and medical instruments, liquid sticks, sealant materials, film separators, and double-structure aerosol systems, among others. It also provides containers for juices, liquid seasonings, detergents and others. The company offer its products under various brands including Mastack, Filmbyna, Culture bag, Agriflex, Filmbyna, Flowpack, Z-tainer and Rectainer. Fujimori is headquartered in Shinjuku, Tokyo, Japan.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Fujimori Kogyo Co., Ltd. – Key Facts 5
Fujimori Kogyo Co., Ltd. – Key Employees 6
Fujimori Kogyo Co., Ltd. – Major Products and Services 7
Fujimori Kogyo Co., Ltd. – History 8
Fujimori Kogyo Co., Ltd. – Company Statement 9
Fujimori Kogyo Co., Ltd. – Locations And Subsidiaries 10
Head Office 10
Other Locations & Subsidiaries 10
Section 2 – Company Analysis 11
Company Overview 11
Fujimori Kogyo Co., Ltd. – Business Description 11
Fujimori Kogyo Co., Ltd. – SWOT Analysis 12
SWOT Analysis – Overview 12
Fujimori Kogyo Co., Ltd. – Strengths 12
Fujimori Kogyo Co., Ltd. – Weaknesses 13
Fujimori Kogyo Co., Ltd. – Opportunities 14
Fujimori Kogyo Co., Ltd. – Threats 15
Fujimori Kogyo Co., Ltd. – Key Competitors 16
Section 3 – Company Financial Ratios 17
Financial Ratios – Capital Market Ratios 17
Financial Ratios – Annual Ratios 18
Performance Chart 21
Financial Performance 21
Financial Ratios – Interim Ratios 22
Financial Ratios – Ratio Charts 23
Section 4 – Appendix 24
Methodology 24
Ratio Definitions 24
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Fujimori Kogyo Co., Ltd., Key Facts 5
Fujimori Kogyo Co., Ltd., Key Employees 6
Fujimori Kogyo Co., Ltd., Major Products and Services 7
Fujimori Kogyo Co., Ltd., History 8
Fujimori Kogyo Co., Ltd., Other Locations 10
Fujimori Kogyo Co., Ltd., Key Competitors 16
Fujimori Kogyo Co., Ltd., Ratios based on current share price 17
Fujimori Kogyo Co., Ltd., Annual Ratios 18
Fujimori Kogyo Co., Ltd., Annual Ratios (Cont...1) 19
Fujimori Kogyo Co., Ltd., Annual Ratios (Cont...2) 20
Fujimori Kogyo Co., Ltd., Interim Ratios 22
Currency Codes 24
Capital Market Ratios 24
Equity Ratios 25
Profitability Ratios 25
Cost Ratios 26
Liquidity Ratios 26
Leverage Ratios 27
Efficiency Ratios 27

★海外企業調査レポート[Fujimori Kogyo Co., Ltd. (7917):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ImevaX GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary ImevaX GmbH (ImevaX) is a biopharmaceutical company that develops novel vaccines to prevent chronic and nosocomial infections. Its lead product candidate IMX101, an immune evasion vaccine, is indicated for the treatment of Helicobacter pylori. Its pipeline products include IMA101 mucosal adj …
  • Almac Group Ltd:企業のM&A・事業提携・投資動向
    Almac Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Almac Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務情報
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Telia Company AB:企業の戦略・SWOT・財務情報
    Telia Company AB - Strategy, SWOT and Corporate Finance Report Summary Telia Company AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • EyePoint Pharmaceuticals Inc (PSDV):企業の製品パイプライン分析2018
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …
  • FirstCash Inc:企業の戦略・SWOT・財務情報
    FirstCash Inc - Strategy, SWOT and Corporate Finance Report Summary FirstCash Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mitsui E&S Holdings Co., Ltd. (7003):企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • bioLytical Laboratories Inc:製品パイプライン分析
    Summary bioLytical Laboratories Inc (bioLytical) is a medical device company that develops and manufactures HIV diagnostic products. The company offers products such as insti HIV-1/HIV-2 antibody test and insti HIV-1/HIV-2 test controls. Its product line provides test results that translates into a …
  • Orica Limited:戦略・SWOT・企業財務分析
    Orica Limited - Strategy, SWOT and Corporate Finance Report Summary Orica Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ArcelorMittal:企業の戦略・SWOT・財務情報
    ArcelorMittal - Strategy, SWOT and Corporate Finance Report Summary ArcelorMittal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Mission Pharmacal Company:企業の戦略・SWOT・財務情報
    Mission Pharmacal Company - Strategy, SWOT and Corporate Finance Report Summary Mission Pharmacal Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Empire Co Ltd:戦略・SWOT・企業財務分析
    Empire Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Empire Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Enlight Renewable Energy Ltd (ENLT):企業の財務・戦略的SWOT分析
    Summary Enlight Renewable Energy Ltd (Enlight Renewable) is a renewable energy company that invests, develops, finances, constructs, operates and manages electricity production projects from renewable energy sources. The company develops photovoltaic technology by which solar energy is converted to …
  • Storz Medical AG:企業の戦略的SWOT分析
    Storz Medical AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Sotera Health LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Sotera Health LLC (Sotera Health), formerly Sterigenics International LLC, a subsidiary of GTCR LLC, is a medical device company. The company offers sterilization technologies such as gamma irradiation, electron beam and ethylene oxide. Its services include drug device combination, vaccine s …
  • Alzheimer’s Drug Discovery Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Alzheimer's Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. It offers servi …
  • Sanford Health-製薬・医療分野:企業M&A・提携分析
    Summary Sanford Health (Sanford) is a healthcare service provider that offers medical services. The center’s medical services include allergy and immunology, acupuncture, adult trauma, airmed, anesthesiology, breast health, behavioral health, pediatric care, bladder health, bleeding disorders, botox …
  • Fidelidade – Companhia de Seguros, S.A.:企業の戦略・SWOT・財務情報
    Fidelidade - Companhia de Seguros, S.A. - Strategy, SWOT and Corporate Finance Report Summary Fidelidade - Companhia de Seguros, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • GE Healthcare LLC:医療機器:M&Aディール及び事業提携情報
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Sygnis AG (LIO1):医療機器:M&Aディール及び事業提携情報
    Summary Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a developer of novel products and tools in the field of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its offers products such as single cell …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆